Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Cheal

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
Microscopy Research and Technique|March 13, 2015
STAQ: A route toward low power, multicolor nanoscopyTilman Rosales, Dan L Sackett, Jianhua Xu, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2015
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugatesSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Bioconjugate Chemistry|April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Molecular Pharmaceutics|April 24, 2018
ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted RadioimmunotherapyBrian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.
Theranostics|August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
EJNMMI Research|January 24, 2016
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modelingEdward K Fung, Sarah M Cheal, Shoaib B Fareedy, et al.
Microscopy Research and Technique|March 13, 2015
STAQ: A route toward low power, multicolor nanoscopyTilman Rosales, Dan L Sackett, Jianhua Xu, et al.
Theranostics|May 7, 2026
Pretargeted <sup>177</sup>Lu/<sup>225</sup>Ac combination therapy of colorectal cancerSara S Rinne, Niloufar Salehi, Brett A Vaughn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
<sup>225</sup>Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast CancerSara S Rinne, Daniela Burnes Vargas, Shin Seo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2015
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugatesSarah M Cheal, Hong Xu, Hong-Fen Guo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Bioconjugate Chemistry|April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy ApplicationsMegan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Molecular Pharmaceutics|April 24, 2018
ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor XenograftsSarah M Cheal, Shutian Ruan, Darren R Veach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted RadioimmunotherapyBrian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.
Theranostics|August 4, 2025
Comparison of targeting two antigens (GPA33 versus HER2) for <sup>225</sup>Ac-pretargeted alpha-radioimmunotherapy of colorectal cancerSara S Rinne, Daniela Burnes Vargas, Brett A Vaughn, et al.
Pageof 5